On Tuesday, investment group Eurazeo announced that it had acquired a stake in Oncodesign Services, a company specializing in drug discovery and pre-clinical services in oncology and immuno-inflammation.
By investing €22 million via its Nov Santé Actions Non Cotées fund, Eurazeo will become a minority shareholder alongside the company's management and Edmond de Rothschild Private Equity.
In a press release, Eurazeo states that its investment has financed the acquisition of Dutch company ZoBio, specialized in preclinical small molecule research.
This first 'transforming' acquisition since the creation of Oncodesign Services aims to form a complete player in pre-clinical research services, with sales of 44 million euros and a workforce of almost 280 employees.
Oncodesign Services is the result of the separation, in 2022, of the Oncodesign group into two independent companies: a biotechnology entity called Oncodesign Precision Medicine, listed on the stock exchange, and a pre-clinical research services arm.
The latter offers a range of services from medicinal chemistry and pharmaco-imaging to molecular radiotherapy and in vitro and in vivo bio-analysis.
Eurazeo currently manages nearly 33.5 billion euros in diversified assets, including over 23 billion euros on behalf of third parties.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Eurazeo SE is a leading European investment group with diversified assets under management of EUR 35 billion, including EUR 24.2 billion on behalf of institutional and individual clients through its private equity, private debt, real estate and infrastructure strategies. The group supports over 600 mid-market companies, leveraging the commitment of its 400 employees, its sector expertise, its privileged access to global markets via 12 offices in Europe, Asia and the United States, and its responsible approach to value creation based on growth. Eurazeo's institutional and family shareholding and its solid financial structure ensure its long-term viability.
Eurazeo SE has offices in Paris, New York, London, Frankfurt, Berlin, Milan, Madrid, Luxembourg, Shanghai, Seoul, Singapore and Saõ Paulo.